increased sensitivity to induced morbidity/mortality_Bcl3<tm1Sbn>/Bcl3<tm1Sbn>

http://metadb.riken.jp/0009763I129S4SvJaeC57BL6Bcl3tm1SbnBcl3tm1SbnBcl3tm1Sbn

increased sensitivity to induced morbidity/mortality_Bcl3<tm1Sbn>/Bcl3<tm1Sbn>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• B cell leukemia/lymphoma 3
  http://metadb.riken.jp/db/mgi_rdf/MGI:88140

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Bcl3<tm1Sbn>/Bcl3<tm1Sbn>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Bcl3<tm1Sbn>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S4/SvJae * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased sensitivity to induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009763

文献

http://purl.org/net/cito/citesAsAuthority

• G. Franzoso, et.al., Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions., Immunity, 1997, 6
  http://rdf.ncbi.nlm.nih.gov/pubmed/9133427